Molecular Tradeoffs in Longevity Biomedicine
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Defining Longevity Biomedicines We distinguish these interventions from standard supplements by their mechanism specificity and their ability to induce durable biological modifications. Rather than just addressing symptoms, these biomedicines aim to target the 14 Hallmarks of Aging, the underlying drivers of cellular decay.
The Landscape Map: From Nodes to Systems Host A and Host B zoom through the levels of biological organization:
- Organism to Molecular Nodes: How systemic changes in tissues—like thymic involution (the shrinking of the thymus)—drive immune senescence and "inflammaging".
- The Growth vs. Maintenance Conflict: A deep dive into mTORC1, the anabolic sentinel that promotes growth but accumulates cellular "clutter," and AMPK, the catabolic fuel gauge that triggers cellular cleaning (autophagy).
The Risks of "Turning Back Time" We examine the high-stakes tradeoffs inherent in modern geroscience:
- The Senescence Paradox: While clearing senescent "zombie cells" with senolytics reduces inflammation, it can inadvertently remove natural barriers to tumor growth, as senescence is a primary tumor-suppressor mechanism.
- Energetic Failure Modes: Why pushing mitochondrial biogenesis and energy production too hard can lead to increased oxidative stress and reactive oxygen species (ROS) damage.
- ECM Stiffening: How the breakdown of the extracellular matrix (ECM) and collagen cross-linking creates mechanical feedback loops that trap tissues in an aged state.
Key Takeaways
- Biology is a Zero-Sum Game: Longevity is often achieved by diverting energy away from growth and reproduction toward repair and maintenance pathways.
- Interconnected Hallmarks: You cannot modify one hallmark, such as mitochondrial dysfunction, without triggering effects in others, like genomic instability or cellular senescence.
- The Proactive Shift: The future of healthcare lies in moving from "reactive" disease management to "proactive" maintenance of systemic homeostasis.
- Fibrosis as a Dead End: Once deep-seated cross-linking occurs in the extracellular matrix, simple metabolic modifiers like Metformin may no longer be able to "reset" the tissue structure.
Featured Pathways & Concepts
- mTORC1/2: The master regulators of protein synthesis and autophagy.
- AMPK: The catabolic sensor that inhibits mTOR and initiates cellular repair.
- SASP: The "inflammatory soup" secreted by senescent cells.
- UPRmt: The mitochondrial unfolded protein response used to maintain protein integrity.
- TGF-β Axis: A central pathway in tissue scarring and fibrosis.
Longevity, Geroscience, mTOR, AMPK, Autophagy, Cellular Senescence, Proteostasis, Inflammaging, Fibrosis, Mitochondria, Hallmarks of Aging, Biomedicine, Translational Biology, Biological Tradeoffs.